Archive > November 2009

Should You Google Or Bing?

admin » 30 November 2009 » In Google, Search Engines » No Comments

Should You Google Or Bing?

This is one question that Google would hate and Microsoft would love netizens to ponder over. Of course, as per the latest ComScore report, Google is still the king of search with US market share of 65.4% in October 2009. And, none of the challengers, and even all of them put together are in a position to dethrone Google. But, there are valid reasons why Google is unsettled these days.

Google claimed the throne of world’s largest search engine (in 2000) within two years of inception (1998) by indexing over one billion URLs. Google should thank Yahoo, the current challenger for claiming that throne. A year later, Google tripled its indexes. In another three years, its index base rose to 6 billion. On July 25, 2008, Google announced that search engine indexed over 1 trillion unique web pages from all over the globe. Of course, Google’s search index span was around 40 billion at that time. Despite, the phenomenal growth in search span, Google lost world’s largest search engine status in July 2008 to a start up Cuil.

Cuil claimed to search more pages on the Web than anyone else—three times as many as Google and ten times as many as Microsoft. Despite such a strong entry cuil fizzled in the very first month. Cuil is now almost written of as it doesn’t feature even in the top 11,000 most trafficked sites. Volume is not the name of the game; relevance is the name of the game.

Continue

Continue reading...

Tags: ,

Medtronic gets FDA warning on heart implant unit

admin » 18 November 2009 » In Defective Products, FDA » No Comments

Medtronic gets FDA warning on heart implant unit

Medtronic said Wednesday it is responding to a warning letter from the Food and Drug Administration about procedures at the Minnesota headquarters of its heart implants division.

medtronic-pain-relief-system

Medtronic said the FDA inspected the Mounds View, Minn., location in August. It found problems with Medtronic’s procedures for preventing and identifying problems with its devices, documenting those problems, and the speed with which it informs the FDA of any issues. The agency also cited problems with Medtronic’s quality control for suppliers.

Medtronic is the world’s largest medical device maker, and the cardiac rhythm disease management unit is its largest business. It makes surgically implanted devices for rapid, slow, and irregular heartbeats, and systems that monitor how those products are working.

Source

Continue reading...

Tags: , ,

FDA: Diabetes drug Byetta linked to kidney problems

admin » 05 November 2009 » In Defective Products, FDA, Mass Tort » No Comments

FDA: Diabetes drug Byetta linked to kidney problems

People with type 2 diabetes who are taking the blood-sugar-lowering drug Byetta may be at increased risk for kidney problems, including kidney failure, the U.S. Food and Drug Administration reported this week.

The drug’s label will be updated to warn doctors and patients about this possible side effect.

Byetta (exenatide) is a relatively new drug and was approved to treat type 2 diabetes in 2005. It’s known as an incretin mimetic and is a synthetic version of a compound found in the venom of a Gila monster, a lizard in the southwestern United States.

Doctors wrote almost 7 million Byetta prescriptions between 2005 and 2008. The drug is injected, and patients and doctors tend to like it because it’s easier to inject than insulin and can promote weight loss in some people.

Continue

Continue reading...

Tags: , ,